Type 2 diabetes

SGLT2 inhibitors vs DPP4 inhibitors compared in inpatients

SGLT2 inhibitors achieve similar glycemic control compared to DPP4 inhibitors in hospitalised patients, without an increase in overall complications, mortality or the risk of hypoglycaemia. A retrospective observational study of the EMR at the Austin Hospital comprised more than 10,000 inpatients with type 2 diabetes aged ≥ 54 years who received at least one oral ...

Already a member?

Login to keep reading.

© 2021 the limbic